http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2025, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 12 Jun 2025 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html <p>TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (&quot;”DiagnaMed” or “DMED&quot;) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors.</p> <p>Mr. Karagiannidis In his continued role as President and CEO of Quebec Innovative Materials Corp. (&quot;QIMC&quot;), will strengthen strategic collaboration and operational alignment between both organizations. His extensive experience in natural hydrogen exploration, http://www.streetinsider.com/Press+Releases/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html Thu, 12 Jun 2025 08:00:00 -0400 DGNMF DMED O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html <p>TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (&quot;”DiagnaMed” or “DMED&quot;) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors.</p> <p>Mr. Karagiannidis In his continued role as President and CEO of Quebec Innovative Materials Corp. (&quot;QIMC&quot;), will strengthen strategic collaboration and operational alignment between both organizations. His extensive experience in natural hydrogen exploration, http://www.streetinsider.com/Press+Releases/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html Thu, 12 Jun 2025 08:00:00 -0400 DGNMF DMED O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html <p>TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (&quot;”DiagnaMed” or “DMED&quot;) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors.</p> <p>Mr. Karagiannidis In his continued role as President and CEO of Quebec Innovative Materials Corp. (&quot;QIMC&quot;), will strengthen strategic collaboration and operational alignment between both organizations. His extensive experience in natural hydrogen exploration, http://www.streetinsider.com/Press+Releases/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html Thu, 12 Jun 2025 08:00:00 -0400 DGNMF DMED O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html <p>TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (&quot;”DiagnaMed” or “DMED&quot;) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors.</p> <p>Mr. Karagiannidis In his continued role as President and CEO of Quebec Innovative Materials Corp. (&quot;QIMC&quot;), will strengthen strategic collaboration and operational alignment between both organizations. His extensive experience in natural hydrogen exploration, http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html Thu, 12 Jun 2025 08:00:00 -0400 DGNMF DMED O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html <p>TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (&quot;”DiagnaMed” or “DMED&quot;) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors.</p> <p>Mr. Karagiannidis In his continued role as President and CEO of Quebec Innovative Materials Corp. (&quot;QIMC&quot;), will strengthen strategic collaboration and operational alignment between both organizations. His extensive experience in natural hydrogen exploration, http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html Thu, 12 Jun 2025 08:00:00 -0400 DGNMF DMED O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html <p>TORONTO, June 12, 2025 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (&quot;”DiagnaMed” or “DMED&quot;) (CSE: DMED) (OTCQB: DGNMF), a Canadian technology innovator specializing in advanced hydrogen extraction technologies, today announced the appointment of John Karagiannidis as President and Chief Executive Officer, succeeding Fabio Chianelli, who is stepping down from his executive positions but will remain actively involved as a member of the Board of Directors.</p> <p>Mr. Karagiannidis In his continued role as President and CEO of Quebec Innovative Materials Corp. (&quot;QIMC&quot;), will strengthen strategic collaboration and operational alignment between both organizations. His extensive experience in natural hydrogen exploration, http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Appoints+John+Karagiannidis+as+President+%26amp%3B+CEO%3B+Fabio+Chianelli+Transitions+to+Director+Role+Strengthening+Strategic+Partnership+with+QIMC+to+Accelerate+Natural+Hydrogen+Development+in+O/24928435.html Thu, 12 Jun 2025 08:00:00 -0400 DGNMF DMED O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Press+Releases/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html <p align="justify">TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is pleased to announce that it is arranging a private placement of a minimum of $400,000 and a maximum of $650,000 of units (each, a “Unit”), at a price of $0.04 per Unit; (the “Offering”). The Offering is being led by EMD Financial Inc.</p> <p align="justify">Each Unit will be comprised of one common share (“Common Share”) in the capital of the Company and one (1) Common Share purchase http://www.streetinsider.com/Globe+Newswire/DiagnaMed+Announces+LIFE+Offering+of+up+to+%24650%2C000/23235690.html Wed, 15 May 2024 18:10:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html <p align="left">TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to announce it has strengthened support for its intellectual property portfolio by being a client of Intellectual Property Ontario (“IPON”) Partner Program and the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) IP Assist program, which combined, offers a potential of $150,000 in non-dilutive funding. The Company has made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercializing http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html Thu, 14 Mar 2024 08:00:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html <p align="left">TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to announce it has strengthened support for its intellectual property portfolio by being a client of Intellectual Property Ontario (“IPON”) Partner Program and the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) IP Assist program, which combined, offers a potential of $150,000 in non-dilutive funding. The Company has made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercializing http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html Thu, 14 Mar 2024 08:00:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html <p align="left">TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to announce it has strengthened support for its intellectual property portfolio by being a client of Intellectual Property Ontario (“IPON”) Partner Program and the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) IP Assist program, which combined, offers a potential of $150,000 in non-dilutive funding. The Company has made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercializing http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html Thu, 14 Mar 2024 08:00:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html <p align="left">TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to announce it has strengthened support for its intellectual property portfolio by being a client of Intellectual Property Ontario (“IPON”) Partner Program and the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) IP Assist program, which combined, offers a potential of $150,000 in non-dilutive funding. The Company has made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercializing http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html Thu, 14 Mar 2024 08:00:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257 http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html <p align="left">TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, is pleased to announce it has strengthened support for its intellectual property portfolio by being a client of Intellectual Property Ontario (“IPON”) Partner Program and the National Research Council of Canada Industrial Research Assistance Program (“NRC IRAP”) IP Assist program, which combined, offers a potential of $150,000 in non-dilutive funding. The Company has made significant progress in its AI algorithms and software and achieved certain research milestones that merit IP protection for commercializing http://www.streetinsider.com/Press+Releases/DiagnaMed+Strengthening+Intellectual+Property+Support+for+CERVAI%E2%84%A2+Brain+Health+AI+Solution/22929608.html Thu, 14 Mar 2024 08:00:00 -0400 A.13296698 A.20466359 DGNMF DMED O.03955888 O.20136967 O.55981257